Clinical trials: Intelligence
Solid Tumors
Caris Molecular Intelligence Registry
This data collection Registry is a multi-center, observational outcomes Database designed to collect data on the demographics, presentation, diagnosis, treatment, resource use, quality of life and outcomes of subjects utilizing…
- Trial name
- CMIR (NCT02678754)
- Testing
- No intervention required, purely observational
- Volunteers
- 4,981 people
- Sponsor
- Caris Science, Inc.
Endoscopic Submucosal Dissection, Endoscopic Submucosal Dissection (ESD)
The Improvement Effect of Real-time Artificial Intelligence Assisted Identification of Bleeding Points on Hemostasis Efficiency in Endoscopic Submucosal Dissection
The goal of this clinical trial is to learn if an artificial intelligence (AI) system that identifies bleeding points in real time can help stop bleeding faster during endoscopic submucosal dissection (ESD) - a minimally invasive…
- Trial name
- NCT07495137
- Testing
- AI real-time assistance in endoscopic submucosal dissection (ESD) for bleeding spot identification and marking
- Volunteers
- 160 people
- Sponsor
- Qilu Hospital of Shandong University
Inflammatory Bowel Diseases
West Hertfordshire Inflammatory Bowel Disease Technology Study
A retrospective and prospective, observational, non-interventional, cohort study to develop quantitative metrics from tools used as standard of care when diagnosing, assessing and monitoring patients with inflammatory bowel…
- Trial name
- WHITS (NCT05000242)
- Where
- United Kingdom
- Volunteers
- 200 people
- Sponsor
- Perspectum
10-second G&R Test
Evaluation of the Screening Effect of Artificial Intelligence Hand Activity Evaluation System for Cervical Spondylosis
The purpose of this study: 1. Build an artificial intelligence screening tool for cervical spondylosis based on hand function analysis; 2. Verify the accuracy of cervical spondylosis screening tools.
- Trial name
- NCT06041542
- Testing
- 10-second hand grip and release test
- Where
- China
- Volunteers
- 1,380 people, healthy volunteers welcome
- Sponsor
- Guangdong Provincial People's Hospital
Brain Tumors
SIMPLIFication of Care Pathways for Patients With Rare Brain Tumors Through Artificial Intelligence
This study focuses on rare brain tumors, which are heterogeneous entities with different morphological, biological, and clinical characteristics.
- Trial name
- SIMPLIF-AI (NCT06878469)
- Testing
- RehaCom
- Where
- 2 sites in Italy
- Volunteers
- 200 people
- Sponsor
- Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Hypertension
AI Activity Study in Patients With Elevated Blood Pressure
In this pilot RCT, a total of 40 adults with hypertension will be randomized to either an artificial intelligence (AI) physical activity intervention group or an active control group with a 1 to 1 ratio after completing a 2-week…
- Trial name
- NCT03969056
- Testing
- Artificial Intelligence (AI) Activity, 10,000 steps
- Where
- United States
- Volunteers
- 7 people, healthy volunteers welcome
- Sponsor
- University of California, San Francisco
Diabetic Retinopathy
The Santa Cruz Diabetic Retinopathy Utilizing Artificial Intelligence Study
In this clinical trial, we plan to evaluate the usefulness of artificial intelligence (AI) software paired with a handheld retinal camera to compare diabetic retinopathy status in Bolivian patients as read by retina specialists…
- Trial name
- SC-DRAI (NCT03912961)
- Testing
- Picture of the retina with a handheld retinal camera
- Where
- 3 sites in Bolivia
- Volunteers
- 1,034 people
- Sponsor
- Retina Global
Cancer, Shared Decision Making
Use of and Attitudes Towards Large Language Models for Health Information Among People With Cancer, the Public, and Health-care Professionals
This cross-sectional survey examined how people with cancer, the general public and health-care professionals use large language models (LLMs) such as ChatGPT for health information, what they expect from them, how comfortable…
- Conditions
- Cancer, Shared Decision Making, Artificial Intelligence
- Trial name
- NCT07526441
- Where
- Germany
- Volunteers
- 6,632 people, healthy volunteers welcome
- Sponsor
- Technical University of Munich
Gastric Cancer, Prehabilitation
Preoperative Home-based Multimodal Prehabilitation Based on 5G + Artificial Intelligence Mobile Health
The goal of this prospective, multicenter, open-label randomized controlled clinical trial is to evaluate whether a home-based, digitally supervised multi-modal prehabilitation intervention can improve functional capacity…
- Trial name
- NCT07755917
- Testing
- mHealth prehabilitation group, ERAS group
- Volunteers
- 490 people
- Sponsor
- The Affiliated Hospital of Qingdao University
Breast Cancer, Colon Cancer
EXoPERT EMERALD Clinical Study
The purpose of this study is to establish a multi-center clinical repository of blood samples to support the development and evaluation of an artificial intelligence-based in vitro diagnostic software.
- Conditions
- Breast Cancer, Colon Cancer, Pancreatic Cancer, Ovarian Cancer
- Trial name
- NCT07186296
- Testing
- EXoPred
- Where
- 9 sites in United States
- Volunteers
- 1,400 people, healthy volunteers welcome
- Sponsor
- EXoPERT
Lung Nodule
Evaluating the Real World Performance of an AI Based Lung Nodule Detection Tool
chest x-rays will be analyzed by AI software for a secondary read of lung nodules. Chest x-rays will either be sent to the AI tool to be read or to radiologists to read.
- Trial name
- NCT06597968
- Testing
- AI Based CAD Software (qXR-Ln)
- Where
- United States
- Volunteers
- 44,900 people
- Sponsor
- University Hospitals Cleveland Medical Center
Stroke, Acute
Whole-process Quality Improvement of Endovascular Treatment Basd on an AI-aided Clinical Feedback System
A clustered randomized control trial to evaluate whether multi-aspect intervention based on an AI-aided clinical feedback system could improve the quality of EVT and functional outcome of patients.
- Trial name
- NCT05874596
- Testing
- AI-aided clinical feedback system coupled with multi-aspect intervention basd on Behaviour Change Wheel model
- Where
- China
- Volunteers
- 1,289 people
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
Hypogonadism, Male, Secondary Hypogonadism
AIM-TEST: Microbiome-Targeted Nutrition for Functional Secondary Hypogonadism
AIM-TEST is a randomized, double-blind, placebo-controlled clinical trial evaluating whether an AI-guided, microbiome-targeted nutritional intervention can increase the body's own testosterone production in men aged 30-65 years…
- Trial name
- AIM-TEST (NCT07761546)
- Testing
- Fixed-Formula Microbiome-Targeted Oral Nutritional Supplement
- Where
- Turkey (Türkiye)
- Volunteers
- 112 people
- Sponsor
- Varol TUNALI
Medical History Taking, Artificial Intelligence in Clinical Workflow
Augmenting Clinical Workflow With a Structured Chatbot for Patient History Collection and Diagnostic Support
Doctors spend much of each visit collecting the patient's medical history, and incomplete histories can delay diagnosis. This study tests an AI chatbot that interviews patients before their appointment and produces a structured…
- Conditions
- Medical History Taking, Artificial Intelligence in Clinical Workflow, Outpatient Clinical Encounter
- Trial name
- CHAT-HX (NCT07860762)
- Testing
- AI-Based Structured History-Taking Chatbot
- Where
- Germany
- Volunteers
- 100 people
- Sponsor
- Massachusetts General Hospital
Anesthesia, General, Postoperative Complications
Pre-operative Characteristics for Prediction of Supraglottic Airway Failure Using Machine Learning (ERICA)
Supraglottic airway devices (SGA) are a safe and well-established technique for airway management. Nowadays, up to 60% of general anaesthetics performed in European countries use SGA.
- Conditions
- Anesthesia, General, Postoperative Complications, Laryngeal Masks, Treatment Failure
- Trial name
- ERICA (NCT06617403)
- Testing
- non
- Where
- 2 sites in Germany
- Volunteers
- 44,000 people
- Sponsor
- University Hospital Ulm
Acute Coronary Syndrome, Percutaneous Transluminal Coronary Angioplasty
Establish a Telecare Model of Acute Coronary Syndrome Patient With Heart Stent Implantation by a Non-invasive Wearable Device and Artificial Intelligence Cloud to Reducing Medical Adverse Events.
Heart disease is still one of the world's most important health problems, and it ranks second among the top ten causes of death among Taiwan.
- Trial name
- NCT04455568
- Testing
- use EKG Wisdom bracelet
- Volunteers
- 400 people
- Sponsor
- Taipei Medical University Shuang Ho Hospital
Atrial Fibrillation (AF)
Artificial Intelligence Mapping and Ablation of Non-Pulmonary Vein Electrical Drivers of AF Study
The goal of this clinical trial is to compare the use of the Vektor Computational ECG Mapping System (vMap®) with pulmonary vein isolation (PVI), to using PVI alone, to treat Atrial Fibrillation (AF) in adults.
- Trial name
- IMPRoVED-AF (NCT06935591)
- Testing
- Pulmonary Vein Isolation, vMap® + Pulmonary Vein Isolation
- Where
- 13 sites in United States, Germany
- Volunteers
- 423 people
- Sponsor
- Vektor Medical
Major Depressive Disorder (MDD)
Evaluating Conversational Artificial Intelligence for Depression Management
The goal of this clinical trial is to evaluate how a conversational method of collecting medical history affects patients' perceptions and experiences compared to clinical care as usual.
- Trial name
- NCT07105397
- Testing
- Conversational AI system vs Usual Care
- Where
- United States
- Volunteers
- 130 people
- Sponsor
- George Mason University
Colorectal Polyp
National Colorectal Polyp Care
This study has three main purposes：screening: the first purpose is to evaluate the diagnostic value of combintion of the life risk factors and immunochemical fecal occult blood test (FIT) on detection of colorectal neoplasia in…
- Trial name
- NCPC (NCT03712059)
- Testing
- FIT test and colonoscopy, Polypectomy and biopsy, Classification
- Where
- China
- Volunteers
- 12,000 people
- Sponsor
- Changhai Hospital
Coronary Stenosis
Automatic Anatomical and Functional Classification of Coronary Arteries With Artificial Intelligence.
The goal of this Category 3 research involving the human person is to predict the measurement of the post-stenosis flow (FFR) using CTTA coupled with an intelligent predictive analysis system and comparing it with invasive…
- Trial name
- COROSCAN-IA (NCT05810610)
- Volunteers
- 1,670 people
- Sponsor
- Institut Mutualiste Montsouris